CETIRIZINE HYDROCHLORIDE
| Brand name | QUZYTTIR |
|---|---|
| Active ingredient | CETIRIZINE HYDROCHLORIDE |
| Strength | 10MG/ML (10MG/ML) |
| Dosage form | SOLUTION |
| Route | INTRAVENOUS |
| Modality | Small molecule |
| FDA approval | October 2019 |
| Marketing status | RX |
| Patent | Expires | Type |
|---|---|---|
| 8314083 | February 2030 | use U-2634 |
| 8263581 | February 2030 | use U-2635 |
| 9180090 | February 2030 | use U-2635 |
| 8513259 | February 2030 | use U-2636 |
| 9119771 | February 2030 | use U-2635 |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.